Bharat Biotech has been granted permission to conduct clinical trials of its Covid-19 vaccine, on children aging between 2 to 18 years, by India’s Drug Regulator.
Knowing that there cannot be a proper opening up until the entire population is vaccinated and protected, the experts in India underlined that there is need to vaccinate people below the age of 18 also.
Covaxine by Bharat Biotech and Covishield by Serum Institute of India, are the two vaccines approved by the government of India in Jaunuary 2021.
US regulators this week gave emergency use authorisation to Pfizer-BioNTech’s Covid-19 vaccine for children aged between 12 and 15. On May 5, Canada become first country in the world to approve Pfizer’s Covid-19 vaccine for ages as young as 12.
Discussion about this post